100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
CITI Training Quiz Questions and Answers 2022 (Verified Answers) $8.49   Add to cart

Exam (elaborations)

CITI Training Quiz Questions and Answers 2022 (Verified Answers)

1 review
 529 views  3 purchases

CITI Training Quiz Questions and Answers 2022 (Verified Answers)

Preview 3 out of 24  pages

  • September 28, 2022
  • 24
  • 2022/2023
  • Exam (elaborations)
  • Questions & answers
All documents for this subject (47)

1  review

review-writer-avatar

By: cardiopoietic • 1 year ago

avatar-seller
Toian
CITI training
1.What must you file before conducting human clinical trials with an exper- imental drug?: IND application (Form FDA 1571)
2.During the clinical development phase of the IND process, what must sponsors do?: Maintain current IND application by amending IND with new Form FDA 1571 and providing FDA with:
safety updates
copies of new protocols FDA 1572
Annual Progress reports
3.this document notifies FDA of relevant changes in investigators conduct- ing clinical trials under the IND.: Form FDA 1572
4.What is the timeline of drug development?: Preclinical trials, IND Submis- sion,
Clinical Development (Phase I-III), NDA submission, Marketing (Phase IV)
5.When does a sponsor submit the IND?: Prior to clinical development phases (human trials). *30 day process.
6.What is the NDA?: New Drug Application, submitted prior to Phase IV market- ing phase.
7.How long does the NDA submission take?: 6 months - 2 years.
8.What is determined for a drug in the preclinical phase: Pharmacokinetics and bioavailability Outcome shows promise of safety and efficacy warranting additional studying.
9.How long does FDA have to review IND submission?: 30 days
10.How long is the clinical development phase (Phase 1-III) in process for IND?: 6-7 years.
11.Determine the trial phase:
-Assess toxicity
-Determine drug's PK and PD profiles
-Determine doses resulting in sufficient biological level of drug: Phase I
12.Determine the trial phase:
-Determine drug's effectiveness (primary goal) -Determine long-term drug safety
-Confirm findings: Phase III .Determine the trial phase:
-Determine drug's short-term risk (safety) (primary goal)
-Examine preliminary effectiveness of drug: Phase II
14.Determine the trial phase from the subject population: Controlled studies enrolling limited numbers of patients: Phase II
15.Determine the trial phase from the subject population:
Controlled and uncontrolled studies (but typically placebo-controlled and double-blinded) enrolling larger patient numbers.: Phase III
16.Determine the trial phase from the subject population:
Normal healthy volunteers unless toxicity prevents exposure (e.g,
cancer drugs). In this, case patients with end-stage disease might be
enrolled.: - Phase I
17.If an IND application is submitted and the FDA has not contacted the physician within 30 days after acknowledging receipt, can the trial start?: - Yes, one of two conditions must be met.
1.30 days elapsed since FDA received IND application and no hold
as been placed.
2.Correspondence has ben received from FDA allowing the trial to start.
18.What must be provided to investigators before they beginning conduct- ing trials at their site?: Protocol and Investigator's Brochure
19.What regulation must a PI comply with in order to use an edc system for a clinical trial?: 21 CFR Part 11
20. 21 CFR 56.115(b):
21. 21 CFR 312.57:
22. 21 CFR 312.62:
23. 21 CFR 812.140:
24.What happened because of the concern and confusion regarding inter-
pretation of Part 11in 2003.: FDA withdrew all the guidance documents
related to Part 11, while re-examining.
They then issued: Guidance for Industry: Part 11, Electronic Records; Electronic Signatures-Scope and Application (2003) and Guidance for Industry: Comput- erized Systems Used in Clinical Investigations (2007). ** The 2007 guidance "supplements the 2003 guidance"
25.Development of most new drugs from discovery to marketing

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Toian. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

73314 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.49  3x  sold
  • (1)
  Add to cart